Etoricoxib CAS 202409-33-4

Khoom Piav Qhia:

Khoom Lub Npe: Etoricoxib CAS TSIS TAU: 202409-33-4

Lub ntsiab lus:

5-chloro-3 (methylsulfonyl) phenyl-2-((4-methyl) -3-pyridyl) -pyridine;

5-Chloro-6' -methyl-3- (4- (methylsulfonyl) phenyl) -2,3' -bipyridine;

5-chloro-3- (4- (methylsulfonyl) phenyl) -2- (Methyl-5-pyridinyl) pyridine;

Tshuaj& Lub Cev Muaj Zog:

Tshwm sim: Off-white hmoov

Kev Ntsuas: ≥99.00%

Ceev: 1.298 g/cm3

Kub Point: 510 ℃ ntawm 760 mmHg

Melting Point: 134-135 ℃

Flash Point: 262.2 ℃

Refractive Index: 1.6

Vapor Siab: 5.17E-10mmHg ntawm 25 ℃

Cov Ntaub Ntawv Kev Nyab Xeeb:

Cov Lus Hais Txog Kev Nyab Xeeb: S26; S36

HS Code: 2933399090

WGK Lub Tebchaws Yelemees: 3

Cov Lus Qhia Risk: R36/37/38

Cov lej phom sij: Xi, T.

Etoricoxib (Arcoxia) yog tus xaiv COX-2 inhibitor los ntawm Merck& Tam sim no nws tau pom zoo hauv ntau dua 80 lub teb chaws thoob ntiaj teb tab sis tsis yog nyob hauv Asmeskas, qhov uas Food and Drug Administration (FDA) tau xav tau kev nyab xeeb ntxiv thiab ua tau zoo cov ntaub ntawv rau etoricoxib ua ntej nws yuav muab kev pom zoo. Labeled Etoricoxib, npaj rau siv ua tus txheej txheem sab hauv rau kev suav ntawm Etoricoxib los ntawm GC- lossis LC-mass spectrometry.

Yog tias koj txaus siab rau peb cov khoom lossis muaj lus nug, thov koj xav tiv tauj peb!

Cov khoom lag luam nyob rau hauv patent tau muab rau R& D lub hom phiaj nkaus xwb. Txawm li cas los xij, lub luag haujlwm zaum kawg tshwj xeeb tshaj yog nrog tus neeg yuav khoom.

Cim npe nrov: etoricoxib cas 202409-33-4, tuam ntxhab, cov chaw muag khoom, lub Hoobkas, yuav, hauv Tshuag

• Tug: Silodosin CAS 160970-54-7
• Tom ntej: PARECOXIB SODIUM CAS 198470-85-8